Zaleplon controlled release - Intec Pharma

Drug Profile

Zaleplon controlled release - Intec Pharma

Alternative Names: Accordion Pill Zaleplon; AP-ZP; Gastric retentive dual release zaleplon AP; The Accordion Pill - Zaleplon; Zaleplon AP; Zaleplon GR

Latest Information Update: 25 Oct 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Intec Pharma
  • Class Acetamides; Hypnosedatives; Pyrimidines; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Insomnia

Most Recent Events

  • 22 Oct 2015 Intec Pharma has patent protection for Accordion Pill platform in Europe
  • 07 Aug 2015 Phase II development is ongoing in USA and Israel
  • 06 Jun 2012 Intec Pharma completes phase-II trials in Insomnia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top